Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297239
Status:
RECRUITING
Last Update Posted:
2024-03-07
First Post:
2024-02-27
Brief Title:
Argentine Registry of Lpa
Sponsor:
School of Medicine National University of Cuyo
Organization:
School of Medicine National University of Cuyo
Study Overview
Official Title:
Argentine Registry for the Study of Lipoprotein a
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GAELpa
Brief Summary:
The Argentine Registry on Lipoproteina LPa orchestrated by the Argentine Group for LPa Study stands as a pioneering and extensive prospective initiative This registry systematically collects geolocation data including patient postal codes demographic information and a multifaceted array of health parameters to unravel the intricate associations surrounding LPa levels
The dataset encompasses diverse patient characteristics ranging from standard metrics like blood pressure weight and race to broader factors such as diabetes smoking habits menopausal status and hypothyroidism This holistic approach enables a nuanced exploration of the interplay between LPa levels and various risk factors providing invaluable insights for both clinical and public health considerations
One distinctive feature of this registry lies in its focus on medication history shedding light on the impact of routine pharmaceutical interventions on LPa profiles Additionally it delves into the intricate web of inflammatory diseases recognizing their potential role in LPa modulation
Genetic predispositions are meticulously examined with a specific emphasis on identifying homozygous and heterozygous variants associated with hypercholesterolemia This genetic dimension adds a layer of complexity to the understanding of LPa dynamics contributing significantly to the ongoing discourse on cardiovascular risk
The prospective nature of this registry allows for dynamic analyses fostering a continuous exploration of emerging patterns and trends By amalgamating geographical clinical and genetic data the Argentine LPa Registry emerges as a comprehensive platform poised to unlock novel facets of LPa biology and its implications for cardiovascular health As the dataset matures it holds the promise of guiding personalized interventions and refining risk stratification strategies thereby advancing the landscape of preventive cardiovascular care
The dataset encompasses diverse patient characteristics ranging from standard metrics like blood pressure weight and race to broader factors such as diabetes smoking habits menopausal status and hypothyroidism This holistic approach enables a nuanced exploration of the interplay between LPa levels and various risk factors providing invaluable insights for both clinical and public health considerations
One distinctive feature of this registry lies in its focus on medication history shedding light on the impact of routine pharmaceutical interventions on LPa profiles Additionally it delves into the intricate web of inflammatory diseases recognizing their potential role in LPa modulation
Genetic predispositions are meticulously examined with a specific emphasis on identifying homozygous and heterozygous variants associated with hypercholesterolemia This genetic dimension adds a layer of complexity to the understanding of LPa dynamics contributing significantly to the ongoing discourse on cardiovascular risk
The prospective nature of this registry allows for dynamic analyses fostering a continuous exploration of emerging patterns and trends By amalgamating geographical clinical and genetic data the Argentine LPa Registry emerges as a comprehensive platform poised to unlock novel facets of LPa biology and its implications for cardiovascular health As the dataset matures it holds the promise of guiding personalized interventions and refining risk stratification strategies thereby advancing the landscape of preventive cardiovascular care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None